HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells

J Neurochem. 2004 Mar;88(6):1439-48. doi: 10.1046/j.1471-4159.2003.02273.x.

Abstract

alpha-Synuclein is a neuronally expressed protein which is mutated in familial Parkinson's disease. We have previously shown that disease-associated mutants of alpha-synuclein cause enhanced neuronal cell death in response to a variety of stimuli, whereas wild-type alpha-synuclein has a protective effect against some stimuli, whilst enhancing the death response to others. We demonstrate, for the first time, that over-expression of the heat shock protein HSP27 has a potent protective anti-apoptotic effect against the damaging effects of wild-type and particularly of mutant alpha-synuclein. In contrast, HSP70 has some protective effect against the damaging effect of the wild-type protein, but has no effect against the mutant proteins, whilst HSP56 has no protective effect in this system. Our results indicate that disease-associated mutants of alpha-synuclein enhance its death-inducing properties and lead to increased apoptosis, which can be mitigated by either the use of specific caspase inhibitors or HSP27 over-expression. This potent protective effect of HSP27 against the mutant and wild-type proteins may be of potential therapeutic importance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Caspase Inhibitors
  • Cell Hypoxia / genetics
  • Cell Line
  • Cricetinae
  • Culture Media, Serum-Free / pharmacology
  • Cytoprotection / genetics
  • Dopamine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Gene Transfer Techniques
  • HSP27 Heat-Shock Proteins
  • HSP70 Heat-Shock Proteins / biosynthesis*
  • HSP70 Heat-Shock Proteins / genetics
  • HSP70 Heat-Shock Proteins / pharmacology
  • Heat-Shock Proteins*
  • Humans
  • In Situ Nick-End Labeling
  • Mice
  • Molecular Chaperones
  • Mutation
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / pharmacology
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / pharmacology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Rabbits
  • Rats
  • Staurosporine / pharmacology
  • Synucleins
  • Tacrolimus Binding Proteins / biosynthesis
  • Tacrolimus Binding Proteins / genetics
  • Tacrolimus Binding Proteins / pharmacology
  • alpha-Synuclein

Substances

  • Caspase Inhibitors
  • Culture Media, Serum-Free
  • Enzyme Inhibitors
  • HSP27 Heat-Shock Proteins
  • HSP70 Heat-Shock Proteins
  • HSPB1 protein, human
  • Heat-Shock Proteins
  • Hsbp1 protein, mouse
  • Hspb1 protein, rat
  • Molecular Chaperones
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • SNCA protein, human
  • Snca protein, mouse
  • Snca protein, rat
  • Synucleins
  • alpha-Synuclein
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 4
  • Staurosporine
  • Dopamine